News
Anthropic’s revenue grew over 10-fold in 2025, but the cost of training and serving its models is also climbing.
The company has a lucrative opportunity in letting rivals tap…
“When my paycheck lands, it takes a detour through bitcoin.”
Indicators are at extremes — stretched valuations are bearish for stocks.
Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said…
Jefferies strategists are talking about a revolution, against AI that is, to help boost stock…
Volatility in the U.S. bond market is picking up this month, with some investors questioning…
The current tariffs imposed by the White House expire in July, close enough to mid-term…
Novo Nordisk’s study showing a new drug wasn’t as good as a rival’s led one…

